Buprenorphine and Morphine Sulfate Liposome: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Morphine Sulfate Liposome
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Buprenorphine and morphine can work against each other. Buprenorphine grabs onto the same pain receptors that morphine uses, but it only partly turns them on and it holds on tightly. When both are in your body, buprenorphine can crowd morphine out. That may mean less pain relief from your morphine, and it can even bring on withdrawal symptoms like sweating, chills, stomach cramps, or feeling shaky.
There is also a smaller, more theoretical concern that both drugs can affect a brain chemical called serotonin, which in rare cases can build up too much. The good news is your care team knows how to handle this. Please talk with your doctor or pharmacist before changing anything.
Mechanism: Buprenorphine is a high-affinity partial mu-opioid agonist that competitively displaces full agonists like morphine at the mu receptor. This can blunt morphine's analgesia and precipitate withdrawal. Additive serotonergic activity raises a theoretical serotonin syndrome risk.
- Direction: Reduced morphine analgesic effect; possible precipitated withdrawal (opioid receptor antagonism, PD interaction, not a prodrug issue).
- Severity/onset: Major; onset unspecified.
- Evidence: Theoretical.
- Management: Avoid concomitant use of morphine with a partial/mixed agonist-antagonist. If serotonergic exposure is unavoidable, monitor closely during initiation and titration for clonus, hyperthermia, agitation, and autonomic instability; discontinue if serotonin syndrome is suspected.
What happens
Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of serotonin syndrome
Interaction Deep Dive
Do not combine morphine with a partial agonist opioid analgesic or with a mixed opioid agonist/antagonist, since doing so can diminish morphine's analgesic effect and may trigger withdrawal symptoms. Furthermore, when morphine is given together with other agents that act on the serotonergic system, monitor the patient closely, particularly at the start of therapy and during dose titration, because the likelihood of serotonin syndrome rises; if it is suspected, stop treatment1234567.
Why it happens (mechanism)
Opioid receptor antagonism; additive serotonergic effects
How to manage this interaction
Your care team will usually avoid combining these two because buprenorphine can reduce morphine's pain relief and may trigger withdrawal. Here is what that looks like in practice:
- Your prescriber may choose one opioid strategy rather than both, and any switch or dose change will be individualized and managed by them.
- Your team may watch you more closely, especially when starting or adjusting doses, for withdrawal or for signs of serotonin syndrome (agitation, fast heartbeat, sweating, shivering, muscle twitching).
Keep taking both exactly as prescribed for now, and contact your pharmacist or prescriber before making any change. Get urgent help if withdrawal or the symptoms above appear.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
Common questions
Can I take Buprenorphine and Morphine Sulfate Liposome together?
Buprenorphine can block morphine's pain relief and may trigger withdrawal, so these are usually not used together; talk to your prescriber or pharmacist before changing anything and watch for withdrawal or serotonin symptoms. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Morphine Sulfate Liposome interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Morphine Sulfate Liposome interaction managed?
Your care team will usually avoid combining these two because buprenorphine can reduce morphine's pain relief and may trigger withdrawal. Here is what that looks like in practice: Your prescriber may choose one opioid strategy rather than both, and any switch or dose change will be individualized and managed by them. Your team may watch you more closely, especially when starting or adjusting doses… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Buprenorphine or Morphine Sulfate Liposome need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (7)
- Product Information: ARYMO(TM) ER oral extended-release tablets, morphine sulfate oral extended-release tablets. Egalet US Inc (per manufacturer), Wayne, PA, 2017. DailyMed
- Product Information: DURAMORPH intravenous, epidural, intrathecal injection, morphine sulfate intravenous, epidural, intrathecal injection. Hikma Pharmaceuticals USA Inc (Per FDA), Berkeley, NJ, 2023. DailyMed
- Product Information: MS CONTIN(R) oral extended-release tablets, morphine sulfate oral extended-release tablets. Purdue Pharma LP (per FDA), Stamford, CT, 2023. DailyMed
- Product Information: Morphine sulfate oral solution, morphine sulfate oral solution. Hikma Pharmaceuticals USA Inc (per FDA), Berkeley Heights, NJ, 2023. DailyMed
- Product Information: Morphine sulfate oral tablets, morphine sulfate oral tablets. Hikma Pharmaceuticals USA Inc.(Per FDA), Berkeley, NJ, 2023. DailyMed
- Product Information: INFUMORPH intrathecal, epidural injection, morphine sulfate intrathecal, epidural injection. Hikma Pharmaceuticals USA Inc (per FDA), Berkeley Heights, NJ, 2023. DailyMed
- Product Information: Morphine sulfate intravenous injection, morphine sulfate intravenous injection. Mallinckrodt Inc (Per FDA), St. Louis, MO, 2023. DailyMed
Keep reading about Buprenorphine
Keep reading about Morphine Sulfate Liposome
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist